We are a privately held, preclinical biotech company, founded in 2019 and located in Aarhus, Denmark.

​

Our mission is to develop a targeted, safe and effective cure for biomedical implant-associated infections reducing the risk of antimicrobial resistance and saving lives.

​

We do so by pioneering scientific breakthroughs in close collaboration with leading experts in infectious diseases and vascular implants, and top scientists from industry and academia.